Cyclophosphamide (CP), also known as cytophosphane among other names, is a medication used as chemotherapy and to suppress the immune system. As chemotherapy it is used to treat lymphoma, multiple myeloma, leukemia, ovarian cancer, breast cancer, small cell lung cancer, neuroblastoma, and sarcoma.
Top 8 manufacturers took 75.4% market share in 2019.

Market Analysis and Insights: Global and United States Cyclophosphamide Market
This report focuses on global and United States Cyclophosphamide market.
In 2020, the global Cyclophosphamide market size was US$ 629.2 million and it is expected to reach US$ 729 million by the end of 2027, with a CAGR of 2.1% during 2021-2027. In United States the Cyclophosphamide market size is expected to grow from US$ XX million in 2020 to US$ XX million by 2027, at a CAGR of XX% during the forecast period.

Global Cyclophosphamide Scope and Market Size
Cyclophosphamide market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Cyclophosphamide market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027.
For United States market, this report focuses on the Cyclophosphamide market size by players, by Type, and by Application, for the period 2016-2027. The key players include the global and local players which play important roles in United States.

Segment by Type
High-Dose
Low-Dose

Segment by Application
Cancer
Autoimmune Diseases
AL Amyloidosis
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

By Company
Baxter
Novartis
Hikma Pharmaceuticals
Amneal Pharmaceuticals LLC
Jiangsu Hengrui Medicine
NorthStar Rx LLC
GLS Pharma
CSC Pharmaceuticals International